Grantham, Mayo, Van Otterloo & Co (GMO)’s Kadant KAI Stock Holding History
Bought
Maintained
Sold
Other funds holding KAI
WA
Grantham, Mayo, Van Otterloo & Co (GMO)'s KAI Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Kadant (KAI) stake by 2% in Q2 2026, buying an estimated $477K and bringing the position to 79,583 shares worth $25M. The position accounts for 0.06% of the portfolio, ranked #157.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in KAI in Q2 2017 and has held it in 19 quarters since. 324 funds tracked by Wall St. Rank hold KAI as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 79,583 shares of Kadant worth $25M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,530 Kadant shares in Q2 2026, an estimated $477K.
- Kadant made up 0.06% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #157 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Kadant in Q2 2017 and has held it in 19 quarters since.
- 324 funds tracked by Wall St. Rank held Kadant as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.